Table 5 Relationship between relative levels of PlGF mRNA (PlGF/G3PDH) and clinico-pathologic characteristics
Variables | No. | PlGF mRNAa (mean ± SD) | P value |
|---|---|---|---|
Sex | |||
Male | 13 | 0.8760 ± 0.2468 | 0.261 |
Female | 8 | 0.9881 ± 0.1461 | |
Histologic type | |||
Squamous | 10 | 0.9706 ± 0.2153 | 0.307 |
Non squamous | 11 | 0.8714 ± 0.2177 | |
Stage | |||
I–II | 10 | 0.7979 ± 0.1744 | 0.011 |
III–IV | 11 | 1.0284 ± 0.1977 | |
Tumour status | |||
T1 | 6 | 0.7939 ± 0.1656 | 0.096 |
T2–4 | 15 | 0.9686 ± 0.2195 | |
Lymph node status | |||
N0 | 8 | 0.8231 ± 0.1640 | 0.116 |
N1–3 | 13 | 0.9775 ± 0.2303 | |
Tissue | |||
Tumour | 21 | 0.9187 ± 0.2171 | <0.005* |
Adjacent normal tissue | 21 | 0.5652 ± 0.2406 |